2/3/2023 7:38:45 AM
Merck: Phase 3 NRG-GY018 Trial Of KEYTRUDA+chemotherapy Meets Primary Endpoint Of PFS For Endometrial Carcinoma
2/2/2023 6:54:18 AM
Merck Q4 GAAP EPS From Cont Opns $1.18; Non-GAAP EPS $1.62
1/27/2023 6:57:14 AM
Merck : FDA Approves KEYTRUDA For Stage IB Or IIIA Patients With Non-small Cell Lung Cancer
1/26/2023 8:10:09 AM
Merck Animal Health Gets FDA Approval Of Expanded Indication For
BRAVECTO Chews For Dogs
1/11/2023 6:49:12 AM
Merck Closes Tender Offer To Acquire Imago BioSciences
12/30/2022 4:26:37 AM
China's NMPA Approves Merck's Covid-19 Antiviral Molnupiravir For Emergency Use
12/22/2022 6:49:47 AM
Merck, Kelun-Biotech Collaborate To Develop Seven Investigational Preclinical ADC For Treatment Of Cancer
12/20/2022 6:48:07 AM
Astellas : FDA Accepts SBLAs For PADCEV Combination For Treatment Of Metastatic Urothelial Cancer